Journal
CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING
Volume 37, Issue 4, Pages 347-356Publisher
WILEY
DOI: 10.1111/cpf.12311
Keywords
cirrhosis; computed tomography; diastolic dysfunction; echocardiography; magnetic resonance imaging; portal hypertension; prolonged QT-interval; systolic dysfunction
Categories
Funding
- Novo Nordisk Foundation
- Novo Nordisk Fonden [NNF11OC1015075, NNF13OC0006329, NNF11OC1014467] Funding Source: researchfish
Ask authors/readers for more resources
Cirrhotic cardiomyopathy (CCM) is characterized by an impaired contractile response to stress, diastolic dysfunction and the presence of electrophysiological abnormalities, and it may be diagnosed at rest in some patients or demasked by physiological or pharmacological stress. CCM seems to be involved in the development of hepatic nephropathy and is associated with an impaired survival. In the field of cardiac imaging, CCM is not yet a well-characterized entity, hence various modalities of cardiac imaging have been applied. Stress testing with either physiologically or pharmacologically induced circulatory stress has been used to assess systolic dysfunction. Whereas echocardiography with tissue Doppler is by far the most preferred method to detect diastolic dysfunction with measurement of E/A- and E/E'-ratio. In addition, echocardiography may also possess the potential to evaluate systolic dysfunction at rest by application of new myocardial strain techniques. Experience with other modalities such as cardiac magnetic resonance imaging and cardiac computed tomography is limited. Future studies exploring these imaging modalities are necessary to characterize and monitor the cardiac changes in cirrhotic patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available